Kidron Miriam bought ORMP
March 17, 2026 · Form 4 insider transaction
Kidron Miriam bought 119,558 shares of Oramed Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
119,558
Price
$0.00
Total value
N/A
InsiderKidron Miriam
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 17, 2026
Filing dateMarch 18, 2026
Shares owned after1,568,222
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in 8 quarterly installments beginning April 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share, of the Issuer.